Archive.org March 2, 2012 Copy of Pharmstar Website Statement - Pharmstar Has Completed All...
3
Request Info rmation To request more information about Aquaprin, please complete the form below. your name your email enter request details here Submit Investor Informa tion 919 794 7000, Press Extension 5 Leadership Team Howard Phykitt Lanny Roof Dr. Antonio Hernandez MD Don Watson Dr.Wayne Hendren Steven J. Hultquist Howard Phykitt Mr. Phykitt has extensive experience in the design and implementation of pharmaceutical manufacturing products. Working with companies such a s Monsanto, Warner-Lambert, Durkee Foods, Johnson & Johnson (McNeil), American Home Produc ts and many other pharmaceutical companies, Mr. Phykitt has been tabbed with the bringing a litany of current name brand products to full production. He began his career with Teledyne Isotopes, developing systems for the detection of radioactivity in the late 50s. He moved into the pharmaceutical manufacturing industry in 1975, developing g ranulation and coating technology that is used today by companies such as Eli Lily and Glaxo Smithkline in the production of pharmaceutical products . In 1984, Mr. Phykitt founded Granutec, Inc. where he developed fluid bed micro-encapsulation for use in t he pharmaceutical and agriculture industries. By 1988, Granutec grew to $6 million in sales, and from there to over $40 million in sales by 1990. In 1993, the company had grown to over $60 million in sales to companies such as Walmart, Eckerd, Perry Drug, and Rite Aid. By 1993, Mr. Phykitt began the research and development of a safer, more effective delivery of aspirin products. By 1997, he had received 3 patents in this developing, and through various vehicles and personal investment, began perfecting the deve lopment of Aquaprin. After over 17 years of res earching, testing, patenting and devel oping Aquaprin, he is now ready to br ing his most important work to the $30 billion pain management indus try. Mr. Phykitt is a member of the American Management Association with fluency in FDA regulatory affairs, quality control and manufacturing. Mr. Phykitt attended Columbia University. Pharmstar Pharmaceuticals , Inc. (PHAR) is a publicly traded company. Pharmstar has completed all patenting of AQUAPRIN™ and the necessary protection of its intellectual property. All research and development of AQUAPRIN™ ha s been completed, and the company is preparing a full scale production facility at its headquarters in Wilson, NC, for retail marketing. Listen to Bill Chappas interview with CEO and Chairman Howard Phykitt Bill Chappas Interview Home Why Aqua pri n? Investor Info Con tac t Us Detailed Prod uct I nfo Sup porti ng Ar tic l http://pharmstarinc.com/investor-info.html Go FEB MAR APR 2 2011 2012 2013 3 captures 2 Mar 12 -2 Jul 12 Close Help Page 1 of 2 Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin 4/29/2013 http://web.archive.org/web/20120302000644/http://pharmstarinc.com/investor-info.html
Transcript of Archive.org March 2, 2012 Copy of Pharmstar Website Statement - Pharmstar Has Completed All...
7/30/2019 Archive.org March 2, 2012 Copy of Pharmstar Website Statement - Pharmstar Has Completed All Patenting of AQUAPRIN
http://slidepdf.com/reader/full/archiveorg-march-2-2012-copy-of-pharmstar-website-statement-pharmstar-has 1/2
Request Information
To request moreinformation about Aquaprin,please complete the form below.
your name
your email
enter request details here
Submit
Investor Information
919 794 7000, Press Extension 5
Leadership Team
Howard PhykittLanny Roof Dr. Antonio Hernandez MDDon WatsonDr.Wayne HendrenSteven J. Hultquist
Howard Phykitt
Mr. Phykitt has extensive experience inthe design and implementation of pharmaceutical manufacturingproducts.
Working with companies such asMonsanto, Warner-Lambert, DurkeeFoods, Johnson & Johnson (McNeil), American Home Products and many other pharmaceutical companies, Mr.
Phykitt has been tabbed with the bringing a litany of current name brandproducts to full production.
He began his career with Teledyne Isotopes, developing systems for thedetection of radioactivity in the late 50s. He moved into thepharmaceutical manufacturing industry in 1975, developing g ranulationand coating technology that is used today by companies such as Eli Lily andGlaxo Smithkline in the production of pharmaceutical products.
In 1984, Mr. Phykitt founded Granutec, Inc. where he developed fluid bedmicro-encapsulation for use in the pharmaceutical and agricultureindustries. By 1988, Granutec grew to $6 million in sales, and from thereto over $40 million in sales by 1990. In 1993, the company had grown toover $60 million in sales to companies such as Walmart, Eckerd, Perry Drug, and Rite Aid.
By 1993, Mr. Phykitt began the research and development of a safer, moreeffective delivery of aspirin products. By 1997, he had received 3 patents inthis developing, and through various vehicles and personal investment, began perfecting the development of Aquaprin.
After over 17 years of researching, testing, patenting and developing Aquaprin, he is now ready to bring his most important work to the $30 billion pain management industry.
Mr. Phykitt is a member of the American Management Association withfluency in FDA regulatory affairs, quality control and manufacturing.
Mr. Phykitt attended Columbia University.
PharmstarPharmaceuticals, Inc.
(PHAR) is a publicly traded company.
Pharmstar hascompleted all patentingof AQUAPRIN™ and thenecessary protection of its intellectual property.
All research anddevelopment of AQUAPRIN™ has beencompleted, and thecompany is preparing afull scale productionfacility at itsheadquarters in Wilson,NC, for retail marketing.
Listen to Bill Chappas
interview with CEO andChairman HowardPhykitt
Bill Chappas Interview
Home Why Aquaprin? Investor Info Contact Us Detailed Product Info Supporting Articl
http://pharmstarinc.com/investor-info.html Go FEB MAR APR
22011 2012 2013
3 captures
2 Mar 12 -2 Jul 12
Close
Help
Page 1 of 2Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin
4/29/2013http://web.archive.org/web/20120302000644/http://pharmstarinc.com/investor-info.html
7/30/2019 Archive.org March 2, 2012 Copy of Pharmstar Website Statement - Pharmstar Has Completed All Patenting of AQUAPRIN
http://slidepdf.com/reader/full/archiveorg-march-2-2012-copy-of-pharmstar-website-statement-pharmstar-has 2/2
Pharmstar Pharmaceuticals Inc (PHAR) 15 minutes
Last 0.002
Change 0.0012
% Change 37.50%
Time 15:29:48
Bid 0.00
Bid Size 0
Ask 0.00
Ask Size 0
Day Low 0.002
Day High 0.0025
Open 0.0022
Prev Close 0.0032
Volume 598,300
10D Ave Vol 1,797,086
Intraday 5 Dy 1 Mo 3 Mo 6 Mo 1 Yr 2 Yr 5 Yr
Hide Volume
©PharmStar Pharmaceuticals, Inc. |3914 Airport Drive Wilson, NC 27896Telephone: 919 794 7000 | Fax: 919 794 7003 | e-mail: [email protected] | Sitemap
Page 2 of 2Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin
4/29/2013http://web.archive.org/web/20120302000644/http://pharmstarinc.com/investor-info.html
